Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

63.30p
   
  • Change Today:
      1.10p
  • 52 Week High: 121.60
  • 52 Week Low: 35.30
  • Currency: UK Pounds
  • Shares Issued: 540.00m
  • Volume: 1,563,632
  • Market Cap: £341.82m
  • RiskGrade: 119

Alliance Pharma Overview

Our Vision is to be a leading international healthcare business, built around products that are clinically valuable to patients.

1 Day Chart (02-02-2023)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 2.7% 0.0%
Div Cover 3.8 2.6
Op Mrgn 13.2% 19.2%
ROCE 46.4%  
Latest F'cast
P/E 9.9 14.0
PEG 0.4 n/a
Pr/Revenue 2.1 2.0
Pr/Book 1.2  
Latest F'cast
Revenue 25.7% 4.9%
PBT 39.5% 80.8%
EPS 25.0% -30.6%
DPS 5.0% 2.8%

Alliance Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 101.64 28.29 5.33p 12.6 0.3 +38% 1.33p 2.0%
31-Dec-18 118.21 22.80 4.54p 14.8 n/a -15% 1.46p 2.2%
31-Dec-19 135.64 31.08 5.09p 16.5 1.4 +12% 0.54p 0.6%
31-Dec-20 129.80 13.02 5.11p 17.1 n/a 0% 1.61p 1.8%
31-Dec-21 163.21 18.16 6.39p 17.0 0.7 +25% 1.69p 1.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alliance Pharma Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 171.22 32.83 4.44p 14.3 n/a -31% 1.74p 0.0%
31-Dec-23 189.57 43.33 5.47p 11.6 0.5 +23% 1.83p 0.0%
31-Dec-24 211.70 50.69 6.66p 9.5 0.4 +22% 1.97p 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Alliance Pharma Company Announcements

Appointment of NED and SID 01-Feb-2023 07:00 RNS
Notification of Major Holdings 30-Jan-2023 17:18 RNS
Full Year Trading Update 17-Jan-2023 07:00 RNS

Alliance Pharma ShareCast News

Alliance Pharma ends year in line with recent fo... 17-Jan-2023 ShareCast
Alliance Pharma adds operations chief to managem... 12-Jan-2023 ShareCast
Alliance Pharma tumbles amid slower market recov... 23-Nov-2022 ShareCast

Alliance Pharma Top Newspaper Links

Drug sales lead the way for Boots as revenues ri... 31-Oct-2008 The Scotsman
Look ahead 13-Sep-2006 Times
Look ahead 12-May-2006 Times

Latest Alliance Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 63.30p
Change Today 1.10p
% Change 1.77 %
52 Week High 121.60
52 Week Low 35.30
Volume 1,563,632
Shares Issued 540.00m
Market Cap £341.82m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
8.38% below the market average8.38% below the market average8.38% below the market average8.38% below the market average8.38% below the market average
62.07% above the sector average62.07% above the sector average62.07% above the sector average62.07% above the sector average62.07% above the sector average
Price Trend
73.16% below the market average73.16% below the market average73.16% below the market average73.16% below the market average73.16% below the market average
16.13% below the sector average16.13% below the sector average16.13% below the sector average16.13% below the sector average16.13% below the sector average
Income
36.41% above the market average36.41% above the market average36.41% above the market average36.41% above the market average36.41% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Growth
13.36% below the market average13.36% below the market average13.36% below the market average13.36% below the market average13.36% below the market average
15.00% above the sector average15.00% above the sector average15.00% above the sector average15.00% above the sector average15.00% above the sector average

What The Brokers Say

Strong Buy 4
Buy 1
Neutral 1
Sell 0
Strong Sell 0
Total 6
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Interim Final
Ex-Div 22-Dec-22 09-Jun-22
Paid 19-Jan-23 07-Jul-22
Amount 0.59p 1.13p

Trades for 02-Feb-2023

Time Volume / Share Price
16:35 1,711 @ 63.30p
16:35 2,361 @ 63.30p
16:35 75,000 @ 63.20p
16:35 105,464 @ 63.30p
16:35 1 @ 63.30p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page